The Quadro-Iliac Plane (QIP) Block in Hip Arthroplasty (QIP in hip)

May 18, 2026 updated by: Tommaso Sorrentino, San Giovanni di Dio Hospital

The Effectiveness of the "Quadro-Iliac Plane Block" in Hip Arthroplasty: A Prospective Observational Clinical Study

The goal of this observational study is to learn about the effectiveness of different locoregional anesthesia techniques, particularly the Quadro-Iliac Plane (QIP) block, in patients undergoing total hip arthroplasty. The main question it aims to answer is:

Does the QIP block improve postoperative recovery and pain control compared to other routinely used locoregional anesthesia techniques in patients undergoing hip replacement surgery?

Participants undergoing hip arthroplasty as part of their standard clinical care will receive one of the locoregional anesthesia techniques already in use at the hospital (including QIP block, fascia iliaca block, PENG block, or others, according to anesthesiologist choice). Postoperative outcomes will be collected prospectively, including quality of recovery (QoR-15 at 24 hours), pain scores at rest and during movement at predefined time points up to 48 hours, analgesic consumption, time to first analgesic request, time to mobilization, and occurrence of complications.

Study Overview

Status

Recruiting

Detailed Description

This prospective, observational, non-interventional clinical study will evaluate postoperative recovery and analgesic outcomes in adult patients undergoing hip arthroplasty who receive locoregional anesthesia techniques already used in routine clinical practice.

The study focuses particularly on the Quadro-Iliac Plane (QIP) block, a recently introduced fascial plane block performed at the posterior-inferior aspect of the quadratus lumborum muscle near its insertion on the iliac crest. The QIP block will be assessed in comparison with other locoregional techniques routinely used for hip surgery, including fascia iliaca block, PENG block, sacral or lumbosacral erector spinae plane block, femoral nerve block, sciatic nerve block, lumbar plexus block, neuraxial anesthesia, or combinations of these techniques.

Patients will not be randomized, and the choice of anesthetic and analgesic technique will be made by the attending anesthesiologist according to standard clinical practice. All blocks will be ultrasound-guided and performed under aseptic conditions using approved local anesthetics. Standard perioperative monitoring, spinal anesthesia when appropriate, postoperative multimodal analgesia, and rescue analgesia will be provided according to institutional protocols.

The primary endpoint will be postoperative quality of recovery, assessed using the Quality of Recovery-15 score 24 hours after surgery. Secondary outcomes will include postoperative pain scores at rest and during movement at predefined time points up to 48 hours, patient satisfaction, total analgesic consumption, time to first rescue analgesic request, time to first mobilization, nausea and vomiting, antiemetic use, and block-related or postoperative adverse events. Safety monitoring will include immediate complications during block performance, early post-block complications, and delayed neurological symptoms assessed up to 7 days after surgery.

The study plans to include at least 40 patients, with a possible sample size of 40-80 cases, and an expected maximum study duration of 18 months.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing hip arthroplasty surgery, either elective or for a proximal femoral fracture

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Patients undergoing hip arthroplasty surgery, either elective or for a proximal femoral fracture
  • Expected postoperative hospital stay ≥ 24 hours
  • ASA physical status I-III
  • Neuraxial and/or locoregional anesthesia according to standard clinical practice
  • Provision of informed consent to participate in the study

Exclusion Criteria:

  • Absence of informed consent
  • Contraindications to locoregional and/or spinal anesthesia
  • Allergy to local anesthetic agents
  • Cognitive impairment preventing reliable assessment of outcomes
  • Coagulation disorders and/or platelet abnormalities
  • Antiplatelet or anticoagulant therapy that contraindicates spinal anesthesia
  • Presence of localized infection or sepsis at the sites to be treated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
QIP
Quadro-Iliac Plane Block
Fascia Iliaca Block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Recovery (QoR)-15 score
Time Frame: 24 hours postoperatively

The Quality of Recovery-15 (QoR-15) is a validated patient-reported outcome measure designed to assess the quality of postoperative recovery across multiple dimensions of physical and psychological well-being.

The questionnaire consists of 15 items, each scored on an 11-point numerical scale, resulting in a total score ranging from:

Minimum score: 0 → extremely poor quality of recovery Maximum score: 150 → excellent quality of recovery

Higher QoR-15 scores indicate a better postoperative recovery experience.

The questionnaire evaluates five key domains:

Pain Physical comfort Physical independence Psychological support Emotional state

24 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: up to 48 hours
Toxicity, PONV, others
up to 48 hours
Postoperative Pain
Time Frame: 0-2-4-6-8-12-24-48 hours after surgery

The Numerical Rating Scale (NRS) is a validated and widely used tool for the assessment of pain intensity in clinical practice and perioperative research.

Patients are asked to rate their pain on a numerical scale ranging from:

0 → no pain 10 → worst pain imaginable

0-2-4-6-8-12-24-48 hours after surgery
First analgesia request
Time Frame: up to 48 hours
Duration of analgesia
up to 48 hours
First mobilization
Time Frame: 24 hours postoperatively
First mobilization of the patient after surgery
24 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

November 1, 2027

Study Registration Dates

First Submitted

May 4, 2026

First Submitted That Met QC Criteria

May 12, 2026

First Posted (Actual)

May 15, 2026

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • QIP_study
  • No other (Other Identifier: Crotone Hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Surgery

Clinical Trials on Fascia iliaca block (FIB)

Subscribe